These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2950422)

  • 21. [Research on antiviral antibodies of human immunodeficiency and markers of hepatitis B in polytransfused renal patients subjected to chronic hemodialysis].
    Romero MS; Lasierra P; Larrad L; Gutiérrez M
    Med Clin (Barc); 1987 May; 88(17):698-9. PubMed ID: 3649527
    [No Abstract]   [Full Text] [Related]  

  • 22. [Study of anti-HTLV-III antibodies in a population of polytransfused patients subjected to hemodialysis].
    Alonso Hernández A; Lueiro F; Sánchez-Guisande Jack D; Pereira García A
    Med Clin (Barc); 1986 Oct; 87(10):436-7. PubMed ID: 3465982
    [No Abstract]   [Full Text] [Related]  

  • 23. [Safety of immunoglobulins in view of the transmission of LAV/HTLV-III].
    Sugg U; Kaufmann R; Gürtler L; Schneider W
    Beitr Infusionther Klin Ernahr; 1987; 18():39-41. PubMed ID: 3326597
    [No Abstract]   [Full Text] [Related]  

  • 24. Lack of antibodies to LAV/HTLV-III in hepatitis B vaccine recipients.
    Papaevangelou G; Roumeliotou-Karayannis A; Kallinikos G; Politou K
    Eur J Epidemiol; 1985 Dec; 1(4):323-5. PubMed ID: 3855141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Milan as possible starting point of LAV/HTLV III epidemic among Italian drug addicts.
    Lazzarin A; Crocchiolo P; Galli M; Uberti Foppa C; Caredda F; Re T; Moroni M
    Boll Ist Sieroter Milan; 1987; 66(1):9-13. PubMed ID: 3304347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Screening of antiviral antibodies of human immunodeficiency in blood donors].
    Gelabert Blanes A
    Med Clin (Barc); 1987 May; 89(1):14-6. PubMed ID: 3475520
    [No Abstract]   [Full Text] [Related]  

  • 27. [Lymphopathic HTLV-III-LAV infection and acquired immunodeficiency syndrome].
    Pokrovskiĭ VV
    Ter Arkh; 1986; 58(10):151-4. PubMed ID: 3541273
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical, immunological, and virological aspects in Japanese hemophiliacs and AIDS patients.
    Abe T
    AIDS Res; 1986 Dec; 2 Suppl 1():S141-6. PubMed ID: 3103637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Value of ELISA in the diagnosis of HTLV-III-LAV infection. Specificity of kits].
    Lazizi Y; Guetard D; Pillot J
    Presse Med; 1986 Dec; 15(43):2169. PubMed ID: 2954072
    [No Abstract]   [Full Text] [Related]  

  • 30. Incidence of LAV/HTLV-III-positive blood donors.
    Laufs R
    Haematol Blood Transfus; 1987; 31():434-5. PubMed ID: 3481760
    [No Abstract]   [Full Text] [Related]  

  • 31. HIV infection in patients on dialysis and after renal transplantation.
    Heering P; Heinzler P; Bach D; Srampical B; Scheid A; Grabensee B
    Clin Nephrol; 1987 Apr; 27(4):212-3. PubMed ID: 3555910
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevalence of HTLV-III/LAV in household contacts of patients with confirmed AIDS and controls in Kinshasa, Zaire.
    Mann JM; Quinn TC; Francis H; Nzilambi N; Bosenge N; Bila K; McCormick JB; Ruti K; Asila PK; Curran JW
    JAMA; 1986 Aug; 256(6):721-4. PubMed ID: 3014178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of HTLV III/LAV and other viral antibodies in normal and at risk populations.
    Ferrante P; Nardi G; Zanchetta N; Salvioni PM; Pagano A
    Boll Ist Sieroter Milan; 1986; 65(5):357-60. PubMed ID: 3030363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-LAV/HTLV-III antibodies in high and low risk groups.
    Zanetti AR; Zehender G; Tanzi E; Rumi MG; Mari D; Ferroni P
    Antibiot Chemother (1971); 1987; 38():167-73. PubMed ID: 3310859
    [No Abstract]   [Full Text] [Related]  

  • 35. [HIV infection and blood donation services].
    Gathof B; Eberle J; Bäcker U; Deinhardt F; Gathof AG
    Internist (Berl); 1988 Feb; 29(2):124-30. PubMed ID: 3286563
    [No Abstract]   [Full Text] [Related]  

  • 36. [HTLV-III antibodies in hemodialysis patients and following kidney transplantation].
    Grabensee B; Heering P; Heinzler P; Passlick J; Scheid A
    Dtsch Med Wochenschr; 1986 Oct; 111(41):1580-1. PubMed ID: 3533491
    [No Abstract]   [Full Text] [Related]  

  • 37. Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1986 Oct; 105(4):558-9. PubMed ID: 3019202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transfusion-associated acquired immunodeficiency syndrome in the United States.
    Peterman TA; Jaffe HW; Feorino PM; Getchell JP; Warfield DT; Haverkos HW; Stoneburner RL; Curran JW
    JAMA; 1985 Nov 22-29; 254(20):2913-7. PubMed ID: 2997493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human immunodeficiency virus infection transmitted from an organ donor screened for HIV antibody--North Carolina.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1987 May; 36(20):306-8. PubMed ID: 3106777
    [No Abstract]   [Full Text] [Related]  

  • 40. Transmission of HTLV III/LAV infection.
    Bruins SC
    Indiana Med; 1986 Oct; 79(10):866-7. PubMed ID: 3465810
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.